Fed Official Hammack Warns of 3% Inflation; BioNTech Halts Cancer Trial
Key Takeaways Cleveland Fed President Beth Hammack predicts inflation will finish 2026 at approximately 3%, missing the central bank's 2% […]
[BrokerRatings]Technology and Financials Lead Recent Analyst Upgrades
Technology leads the charge with 3 stocks (NVDA, MSFT, AAPL) recently rated strong buy by analysts this Tuesday. Financial giants
[Earnings]AI and Cloud Giants Anchor Heavy Mid-Week Earnings Slate
Broadcom headlines a massive Wednesday after-close surge in technology and software alongside Salesforce and Snowflake. Next Tuesday features a cybersecurity
[EconCal]Jackson Hole and Labor Data Drive Market Volatility
Jackson Hole Symposium continues Friday and Saturday, with Chair Warsh speaking today at 10:00 am alongside critical NFP benchmark revisions.
[DowJonesToday]Dow Jones Industrial Average Climbs as Inflation Data Bolsters Soft Landing Hopes
The Dow Jones Industrial Average showed resilience during Friday’s session, as Dow Futures (YM=F) was up 95.00 (0.1772%) points today.
Goldman Sachs Lifts Japan Stock Outlook as Drone Strikes Cripple Black Sea Oil Exports
Key Takeaways Goldman Sachs (GS) raised its 12-month target for Japan’s TOPIX index to 4,600, up from the previous forecast
Tech Earnings and Economic Data Guide Premarket Sentiment on Friday
Market Overview and Premarket Activity As the final trading session of the week begins on Friday, August 28th, 2026, investors
Canada GDP Rebounds in Q2 as Trump Targets Meat “Monopoly”
Key Takeaways Canada’s economy grew at an annualized rate of 3.3% in Q2 2026, a sharp rebound from a revised
Russian Attacks Devastate 90% of Ukraine’s Food Logistics Infrastructure
Key Takeaways 90% of Ukraine's agricultural warehouses and retail logistics infrastructure have been destroyed by Russian attacks, primarily due to
PBOC Bolsters Property Sector as Eli Lilly’s Mounjaro Secures FDA Heart Health Nod
Key Takeaways Eli Lilly (LLY) received FDA approval for Mounjaro to reduce major cardiovascular risks in adults with type 2